No Data
No Data
Hong Kong Stock Market Changes | Hygeia Health (06078) is up more than 4% now, new acquisition of hospital contributes to performance. Nomura expects to achieve record high first-half results.
Hygeia Health (06078) has risen over 4% and as of press time, it rose 3.58% to HK$27.5 with a turnover of HK$17.4431 million.
Nomura Adjusts Hygeia Healthcare's Price Target to HK$50.70 From HK$58.20, Keeps at Buy
Nomura: Maintains a 'buy' rating for Hygeia Health (06078) and lowers the target price to HKD 50.7.
Nomura has lowered its revenue forecasts for Hygeia Health for the next two years by 3.3% and 5.5% respectively.
The Recent 3.3% Gain Must Have Brightened CEO Yiwen Zhu's Week, Hygeia Healthcare Holdings Co., Limited's (HKG:6078) Most Bullish Insider
Soochow Securities: "Implementation Plan for Supporting the Development of Innovative Drugs Across the Entire Chain" Approved, and the innovative drugs sector is expected to strengthen.
Soochow Securities released research reports stating that the specific provisions of the "Implementation Plan for Full-chain Support of Innovative Drug Development" are expected to be implemented soon. In addition, the innovative drug sector is currently at a historically relatively low level. In the second half of the year, there will be multiple catalysts such as the ESMO conference, WCLC conference, medical insurance negotiations, and expectations for the innovative drug sector going global, which may lead to a strong performance in the innovative drug sector.
Hygeia Health (06078.HK) received a shareholding of 728,600 shares from FIL Limited.
According to the latest equity disclosure information of the Stock Exchange, on June 20, 2024, hygeia health (06078.HK) received FIL Limited's shareholding of 728,600 shares at an average price of HK$30.3388 per share, involving about HK$22.105 million. After the shareholding, FIL Limited's latest number of shares held increased from 4.92% to 5.04%.
No Data